卖什么
医疗AI
商业模式拆解
买家：谁掌握预算？
未核实Hospital radiology and neurology departments (large hospitals on-premise; small hospitals subscribing).
触发点：什么让他们现在购买？
MRI waits of 2-3 months at university hospitals, high cost, and scan limits for claustrophobic or metal-implant patients, so hospitals want MRI-level analysis from routine CT.
工作流：什么输入变成什么输出？
BrainCura auto-segments a CT brain scan into 98 regions, measures volumes vs age norms, produces atrophy/brain-age/Alzheimer-tracking reports and sends results to PACS.
经济账：省了什么，怎么收费？
Software licence: on-premise installs for large hospitals and SaaS subscription for small hospitals and overseas; targets FDA and CE approval.
渠道：怎么接触到客户？
Direct sales to hospitals in Korea first, then global partnerships (SE Asia, US, Japan) after FDA/CE.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-07-16 | 种子轮 | 4억원 | FuturePlay | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-13.